Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin in patients on regular haemodialysis (AURORA)
NCT00240331Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2003
- Primary completion
- Oct 2008
- Modality
- Orthosteric Ligands
- Countries
- 25
01
Overview
A Phase 3 trial of rosuvastatin in hypercholesterolemia, sponsored by AstraZeneca. Started Jan 2003; status: completed.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00240331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00240331.